Image (61c99eec 4bd5 4f46 931b 26b58f67e6a5 546 2)
Topiramate Tablet, Film Coated
Product Images NDC 71205-195
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71205-195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (74b72b34 291e 4a5c 96b1 7f05d629bd47 01)
Image (74b72b34 291e 4a5c 96b1 7f05d629bd47 02)
This appears to be a chart showing the cumulative rates for time to first seizure, with time on the x-axis and cumulative rate on the y-axis. Two different treatments are being compared: topiramate 50 mg/day and topiramate 400 mg/day. The sample size for each treatment is given (N=234 and N=236). There are no further details available.*
Image (74b72b34 291e 4a5c 96b1 7f05d629bd47 03)
71205-195-30 (74b72b34 291e 4a5c 96b1 7f05d629bd47 06)
This is a description of a medication called Topiramate 100mg, packaged in a container of #30 tablets. The medication is film-coated and contains Topiramate. The manufacturer is Unichem Laboratories LTD in India, and it was packaged in Thousand Oaks, California. The medication should be kept at 20°-25°C (68°-77°F) and out of the reach of children. There are three different lots of this medication identified with different lot numbers and expiration dates. The National Drug Code (NDC) for this medication is 71205-195-30, and the GTIN is 0371205195304. The accompanying Medication Guide is required to be received by each patient.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
